CardioVisual
Share
Clinician-led medical education. Heart · Diabetes · Wellness.
720K+ followers · 500K+ clinicians worldwide.
→ Clinician Hub: hcp.medicalvisual.com
Heart disease is #1 killer worldwide.Improve awareness with trusted information. CardioVisual is a health educational app that was created by US cardiologists. It provides a library of trusted, concise & shareable videos of cardiovascular, diabetes, heart health, and wellness information. CardioVisual was awarded 2018 & 2019 ‘Best App for Heart Disease” by Healthline Media. Over half a million cli
06/03/2026
CPR Awareness Week is a reminder that bystander CPR remains one of the strongest determinants of survival in out-of-hospital cardiac arrest. Survival roughly doubles when CPR is initiated before EMS arrival, yet bystander CPR rates remain under 40% in most regions.
For clinicians, the week is also a prompt to think beyond our own competency: Are the people around us, family, gym staff, school personnel, colleagues outside healthcare, prepared to act in the first few minutes? Those minutes decide the outcome long before advanced care begins.
Hands-only CPR is the current AHA recommendation for untrained bystanders.
Early recognition, high-quality compressions, and rapid AED use remain the core of the chain of survival.
Follow for clinically grounded, visual medical education.
The CHAMPION trial is reshaping how we think about shared decision-making in AF management, and Dr. Luigi Di Biase explains why.
For patients with high CHA₂DS₂-VASc scores, successful ablation alone may not translate to safe anticoagulation discontinuation. That reality brings the Watchman procedure back into the conversation, and puts the patient at the center of it.
Dr. Di Biase makes the case for concomitant AF ablation and left atrial appendage occlusion: weighing the long-term risks of anticoagulation against procedural risk, and letting that calculus be driven by individual patient profile and informed preference.
Swipe to hear his perspective.
More conversations with EP exeperts, including the latest trials, emerging treatments, procedural innovations, and clinical decision-making in EP is available on the CardioVisual clinician platform. Be among the first to access it only on hcp.medicalvisual.com.
Sudden cardiac arrest vs sudden cardiac death:
Sudden cardiac arrest (SCA) is the abrupt cessation of effective cardiac mechanical activity, most commonly triggered by a ventricular arrhythmia. It is potentially reversible with prompt intervention, defibrillation, CPR, and advanced resuscitation.
Sudden cardiac death (SCD) is the outcome when SCA goes unwitnessed, unrecognized, or untreated. Death is confirmed. The window between the two is narrow.
During CPR Awareness Week, it is worth reinforcing that survival is possible, but only when the chain of survival holds. Recognition, response time, and access to defibrillation remain the most modifiable variables in outcomes.
Follow for clinically grounded visual education across cardiology, electrophysiology, and beyond.
05/30/2026
We Asked Chat-GPT to analyse and interpret this Echo.
Swipe through to see what it said and let us know, how did it do? Do you think AI can be trusted with this level of interpretation?
Drop your thoughts in the caption.
⚠️ Disclaimer:
This post is for educational purposes only. The analysis shown was generated by an AI model and should not be used for diagnosis or clinical decision-making. Always consult a qualified medical professional for interpretation of imaging and patient care.
Follow for clinically grounded, visual education on cardiology, vascular health, and cardiometabolic disease.
Pulsed field ablation is reshaping how electrophysiologists approach atrial fibrillation, but how is it actually changing clinical management in practice?
We sat down with top EPs to discuss how PFA is influencing the trajectory of AF ablation.
For the full conversation, visit the MedicalVisual clinician hub to watch, learn, share, and discuss with expert faculty and peers across EP at hcp.medicalvisual.com!
05/28/2026
We Asked Claude to analyse and assess a common acute ischemic stroke patient scenario.
Swipe through to see what it said and let us know, how did it do? Do you think AI can be trusted with this level of interpretation?
Drop your thoughts in the caption.
⚠️ Disclaimer:
This post is for educational purposes only. The analysis shown was generated by an AI model and should not be used for diagnosis or clinical decision-making. Always consult a qualified medical professional.
Want to learn more about stroke, brain and cardiac connection?
Visit the MedicalVisual Clinician Hub to learn, ask and discuss directly with clinician experts for free!
Visit here: hcp.medicalvisual.com
SGLT2 inhibitors are now central to heart failure and CKD management, but the mechanism begins with a renal defect in type 2 diabetes.
In T2DM, the kidney upregulates SGLT2 transporters, raising the glucose reabsorptive threshold and retaining glucose that should be excreted. This worsens hyperglycemia and feeds downstream cardiometabolic injury: endothelial dysfunction, volume overload, and adverse myocardial remodeling.
SGLT2 inhibitors reverse this by lowering the threshold for glucosuria. The effects extend well beyond glycemic control: natriuresis, preload reduction, and nephroprotection.
In this excerpt, Dr. Ralph A. DeFronzo, a pioneer of SGLT2 inhibitor therapy, explains the renal physiology behind this drug class.
His full lecture series, The Ominous Octet, is available exclusively on MedicalVisual Clinician Hub, covering eight pathophysiologic defects driving T2DM and their cardiometabolic consequences.
Visit Hcp.medicalvisual.com to access his lecture series!
Dr. DJ Lakkireddy from Kansas City shares a special invitation to EP Live Austin 2026 and explains why this immersive, unscripted experience is a must-attend for the global electrophysiology community.
EP Live is a premier, case-based conference that brings together the world's leading electrophysiologists. This year’s dynamic program features high-impact, live cases, offering an unfiltered look at advanced mapping and ablation strategies, complex arrhythmias, and real-time clinical decision-making.
This isn't passive learning—it’s an interactive, global experience where elite operators tackle challenges live, and world-renowned experts break down every move with practical insights you can immediately apply to your practice.
Registration is free. Join your peers in person in Austin or connect remotely from anywhere in the world.
📅 May 28–29, 2026 📍 St. David's Medical Center, Austin, TX (or Remote)
Comment ""EP"" to get your registration link!
05/25/2026
A pattern that looks like a STEMI, but isn’t.
The Spiked Helmet Sign is one of those ECG findings you don’t forget once you’ve seen it. Convex ST elevation followed by a sharp, spike-like deflection. It mimics ischemia, but the mechanism is very different.
This pattern is most often seen in critically ill patients and is strongly associated with massive intra-abdominal or intrathoracic pressure, often signaling severe systemic distress. The mortality signal here is high.
Curious how to identify high risk ECGs in real time?
Watch the High Risk ECG Interpretation course by Jen Carlquist from on Medical Visual Clinician Hub.
Visit hcp.medicalvisual.com to learn now!
Dr. Andrea Natale, cardiac electrophysiologist at Texas Cardiac Arrhythmia, shares what to expect at EP Live Austin 2026, and why this year's program stands out.
EP Live is a case-based conference held every two years, now in its 16th year. The format centers on recorded and live cases with discussion focused on technique, technology, and patient management.
One of the technologies Dr. Natale will be presenting is FARAFLEX™ mapping and pfa catheter, an integrated mapping and ablation platform currently under clinical investigation
Registration is free. Join in person in Austin or attend remotely.
May 28–29, 2026, St. David's Medical Center, Austin, TX.
Register here: whova.com/portal/registration/7O1w3ExR7W@UDWMEMycx
Click here to claim your Sponsored Listing.